Skip to main content

Modulation of JAK/STAT Pathways in Cancer by Phytochemicals

  • Living reference work entry
  • First Online:
Handbook of Oxidative Stress in Cancer: Mechanistic Aspects

Abstract

Cancer remains a global major health burden. Activation of certain signaling pathways such as Janus kinase (JAK)/signal transducer and activator of transcription (STAT) is found to be an important regulatory defect present in most cancerous cells amongst other factors. The signaling of Cytokine causes the activation of “STAT proteins” in regulating the proliferation and differentiation of cells, more so its role in the modulation of targeted genes cannot be over emphasized. Phytochemicals play significant role in the inhibition of the JAK/STAT signaling in antigen-presenting cells by targeting different pathways. In this review, Resveratrol, cucurbitacin, curcumin, Epigallocatechin-3-gallate and others are promising phytochemicals discussed. Extensive studies have now shown that phytochemicals perform crucial functions in inhibiting the multiplication and proliferation of cancerous cell thus providing novel channels for targeting cancer therapeutically.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Similar content being viewed by others

References

  • Aaronson DS, Horvath CM (2002) A road map for those who don’t know JAK-STAT. Science 296(5573):1653–1655

    Article  CAS  Google Scholar 

  • Ahles TA, Saykin AJ (2007) Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer 7:192–201

    Article  CAS  Google Scholar 

  • Arumuggam N, Bhowmick Neil A, Rupasinghe H, Vasantha P (2015) Phytochemicals targeting JAK/STAT Signaling and IDO expression in Cancer. Phytother Res Rev 29(6):805–817

    Article  CAS  Google Scholar 

  • Bousoik E, Montazeri Aliabadi H (2018) “Do we know Jack” about JAK? A closer look at JAK/STAT signaling pathway. Front Oncol 8:287

    Article  Google Scholar 

  • Darnell J, Kerr I, Stark G (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415–1421

    Article  CAS  Google Scholar 

  • Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2013) Cancer incidence and mortality worldwide. International Agency for Research on Cancer: GLOBOCAN 2012 v1.0. Available from http://globocan.iarc.fr. Accessed on 15/07/2014

  • Fujiki H, Sueoka E, Ravangkan A, Suganuma M (2017) Human cancer stem cells are a target for cancer prevention using (−) epigallocatechin gallate. J Cancer Res Clin Oncol 143(12):2401–2412

    Google Scholar 

  • Groner B, von Manstein V (2017) Jak Stat signaling and cancer: opportunities, benefits and side effects of targeted inhibition. Mol Cell Endocrinol 451:1–14

    Article  CAS  Google Scholar 

  • Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674

    Article  CAS  Google Scholar 

  • Hayashi Y (1992) Overview of genotoxic carcinogens and nongenotoxic carcinogens. Exp Toxicol Pathol 44:465–471

    Article  CAS  Google Scholar 

  • Horvath CM (2000) STAT proteins and transcriptional responses to extracellular signals. Trends Biochem Sci 25:496–502

    Article  CAS  Google Scholar 

  • Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90

    Article  Google Scholar 

  • Khan F, Niaz K, Maqbool F, Hassan FI, Abdollahi M, Kalyan C, Venkata N, Nabavi SM, Bishayee A (2016) Molecular targets underlying the anticancer effects of quercetin: an update. Nutrients 8:529

    Article  Google Scholar 

  • Loveth OL, Christian H, Raphael NA, Wen Z, Lianwen Q (2017) Targeting the key factors of inflammation in cancer: plant intervention. Int J Clin Exp Med 10(12):15834–15865

    Google Scholar 

  • Luch A (2005) Nature and nurture—lessons from chemical carcinogenesis. Nat Rev Cancer 5:113–125

    Article  CAS  Google Scholar 

  • Luo NA, Balko JM, Badve S, Kumar GL (2019) Role of JAK-STAT pathway in cancer signaling. In: Badve S., Kumar G. (eds) Predictive biomarkers in oncology. Springer, Cham. pp 311–319 https://doi.org/10.1007/978-3-319-95228-4_26

  • Messina JL, Yu H, Riker AI, Munster PN, Jove RL, Daud AI (2008) Activated Stat-3 in melanoma. Cancer Control 15(3):196–201

    Article  Google Scholar 

  • Nandakumar V, Singh T, Katiyar SK (2008) Multitargeted prevention and therapy of cancer by proanthocyanidins. Cancer Lett 269:378–387

    Article  CAS  Google Scholar 

  • O’Shea JJ, Schwartz DM, Villarino AV, Gadina M, McInnes IB, Laurence A (2015) The JAK-STAT pathway: impact on human disease and therapeutic intervention. Annu Rev Med 66:311–328

    Article  Google Scholar 

  • Oliveira PA, Colaço A, Chaves R, Guedes-Pinto H, DeLa-Cruz L, Lopes C (2007) Chemical carcinogenesis. Ann Braz Acad Sci 79(4):593–616

    Article  CAS  Google Scholar 

  • Pencik J, Pham HT, Schmellerl J, Javaheri T, Schlederer M, Culig Z et al (2016) JAK-STAT signalling in cancer: from cytokines to non-coding genome. Cytokine 87:26–36

    Article  CAS  Google Scholar 

  • Pitot HC, Goldsworthy T, Moran S (1981) The natural history of carcinogenesis: implications of experimental carcinogenesis in the genesis of human cancer. J Supramol Struct Cell Biochem 17:133–146

    Article  CAS  Google Scholar 

  • Seif F, Khoshmirsafa M, Aazami H, Mohsenzadegan M, Sedighi G, Bahar M (2017) The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells. Cell Commun Signal 15:23

    Article  Google Scholar 

  • Senggunprai L, Kukongviriyapan V, Prawan A, Kukongviriyapan U (2014) Quercetin and EGCG exhibit chemopreventive effects in cholangiocarcinoma cells via suppression of JAK/STAT signaling pathway. Phytother Res 28:841–848

    Article  CAS  Google Scholar 

  • Siegel R, DeSantis C, Virgo K et al (2012) Cancer treatment and survivorship statistics. CA Cancer J Clin 62:220–241

    Article  Google Scholar 

  • Thomas SJ, Snowden JA, Zeidler MP, Danson SJ (2015) The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours. Br J Cancer 113(3):365–371

    Article  CAS  Google Scholar 

  • Vlahopoulos SA, Cen O, Hengen N, Agan J, Moschovi M, Critselis E, Adamaki M, Bacopoulou F, Copland JA, Boldogh I, Karin M, Chrousos GP (2015) Dynamic aberrant NF-κB spurs tumorigenesis: a new model encompassing the microenvironment. Cytokine Growth Factor Rev 26(4):389–403

    Article  CAS  Google Scholar 

  • Wilks AF et al (1991) Two novel protein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinase. Mol Cell Biol 11:2057–2065

    CAS  PubMed  PubMed Central  Google Scholar 

  • Zhang J (2012) Can we discover “really safe and effective” anticancer drugs? Adv Pharmacoepidemiol Drug Saf 01(05)

    Google Scholar 

  • Zhao Y, Hu X, Zuoc X, Wang M (2018) Chemopreventive effects of some popular phytochemicals on human colon cancer: a review. Food Funct 9:4548–4568

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Olorunfemi R. Molehin .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Singapore Pte Ltd.

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Molehin, O.R. et al. (2021). Modulation of JAK/STAT Pathways in Cancer by Phytochemicals. In: Chakraborti, S., Ray, B.K., Roychowdhury, S. (eds) Handbook of Oxidative Stress in Cancer: Mechanistic Aspects. Springer, Singapore. https://doi.org/10.1007/978-981-15-4501-6_88-1

Download citation

  • DOI: https://doi.org/10.1007/978-981-15-4501-6_88-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-15-4501-6

  • Online ISBN: 978-981-15-4501-6

  • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics